CLINICAL_TRIALS
trial_result
· 2023-07-21
Clinical Trial Update: Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis [Phase 2]
Summary
Phase 2 clinical trial evaluating PCS12852 for safety, pharmacokinetics, and efficacy in improving gastric emptying in adults with gastroparesis has been comple…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Processa Pharmaceuticals | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED | Results posted: 2023-07-21